We are excited to share our paper describing neutralising monoclonal antibodies against human coronavirus NL63, an alphacoronavirus that uses the same ACE2 receptor as SARS-CoV and SARS-CoV-2, but generally only causes mild respiratory illness. www.nature.com/articles/s44...

Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus - npj Viruses

npj Viruses - Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus

nature.com

New research from @thedohertyinst.bsky.social suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an important strategy for providing #immunity quickly during a pandemic or disease #outbreak. #ReadTheJI #immunology ow.ly/c28N50VeRGR

Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2

Abstract. Human clinical trials have reported immunological outcomes can differ between ipsilateral (same side) and contralateral (alternate sides) prime-b

ow.ly

1/ Hot off the press in @jimmunol.bsky.social. We investigated how same side (ipsilateral) vs alternate side (contralateral) prime-boost vaccination impacts germinal center (GC) dynamics & antibody responses against SARS-CoV-2 spike in mice.💉🦠#immunology #vaccines @thedohertyinst.bsky.social

Check out the latest from @skentskent.bsky.social and team - how does co-administration of influenza and COVID-19 vaccines affect immunity? Congrats to Wen Shi Lee, Kevin Selva and Jen Audsley on a great study and collaboration between the ViralVax and Chung labs! insight.jci.org/articles/vie...

Waggoner Lab@labwaggoner.bsky.social · 2y ago

Influenza vaccination is equivalently immunogenic if given in same or opposite arms as the SARS-CoV-2 vaccine, but it may be preferable to administer the SARS-CoV-2 vaccine at a different site to influenza vaccines insight.jci.org/articles/vie... @jci-insight.bsky.social